标题
Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
作者
关键词
-
出版物
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-06-16
DOI
10.1007/s11010-022-04483-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rhenium Perrhenate (188ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells
- (2022) Samieh Asadian et al. Cells
- Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches
- (2021) Zahra Farzaneh et al. Cancer Cell International
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
- (2021) Navid Sobhani et al. Cancers
- Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
- (2021) Bahare Shokoohian et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Extracellular vesicles as a next-generation drug delivery platform
- (2021) Inge Katrin Herrmann et al. Nature Nanotechnology
- Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer
- (2021) Alfredo Tartarone et al. Frontiers in Oncology
- Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects
- (2021) Raheleh Roudi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application
- (2020) Yang Ge et al. CANCER LETTERS
- MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
- (2020) Guohua Lou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Extracellular vesicles as drug delivery systems: Why and how?
- (2020) Omnia M. Elsharkasy et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
- (2020) Wioletta Olejarz et al. Journal of Immunology Research
- Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review
- (2020) Bin Li et al. Frontiers in Immunology
- Extracellular Vesicles as Delivery Vehicles of Specific Cellular Cargo
- (2020) Bilal Mir et al. Cells
- Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial
- (2020) Jun Li et al. Lancet Gastroenterology & Hepatology
- β-radiating radionuclides in cancer treatment, novel insight into promising approach
- (2020) Samieh Asadian et al. PHARMACOLOGICAL RESEARCH
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029
- (2019) Mathilde Bonnet et al. Cancers
- Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
- (2019) Reina Sasaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
- (2019) Thomas Yau et al. JOURNAL OF CLINICAL ONCOLOGY
- Glycolytic Activation of Peritumoral Monocytes Fosters Immune Privilege via PFKFB3-PD-L1 axis in Human Hepatocellular Carcinoma
- (2019) Dong-Ping Chen et al. JOURNAL OF HEPATOLOGY
- Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
- (2019) Changhoon Choi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
- (2019) Edo Kon et al. DRUG RESISTANCE UPDATES
- Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis
- (2019) Alfredo Tartarone et al. Future Oncology
- Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer
- (2019) Di (Maria) Jiang et al. Oncotarget
- Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
- (2019) Kostandinos Sideras et al. Scientific Reports
- HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape
- (2019) Qiuju Han et al. Cells
- Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals
- (2019) Wenjuan Dai et al. Cell Communication and Signaling
- Exosomes derived from HCC cells with different invasion characteristics mediated EMT through TGF-β/Smad signaling pathway
- (2019) Zhen Qu et al. OncoTargets and Therapy
- Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
- (2019) Longo et al. Medicina-Lithuania
- The role of exosomal PD-L1 in tumor progression and immunotherapy
- (2019) Feiting Xie et al. Molecular Cancer
- Treatment of Hepatocellular Carcinoma by Intratumoral Injection of 125I-AA98 mAb and Its Efficacy Assessments by Molecular Imaging
- (2019) Jun Zhou et al. Frontiers in Bioengineering and Biotechnology
- Immunotherapy for hepatocellular carcinoma
- (2019) Yin Zongyi et al. CANCER LETTERS
- Endoglin based in vivo near-infrared fluorescence imaging of tumor models in mice using activatable liposomes
- (2018) Felista L. Tansi et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Combination of 131I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma
- (2018) Chongling Duan et al. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
- Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma
- (2018) Furong Liu et al. BULLETIN DU CANCER
- Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress
- (2018) Meng Lu et al. HEPATOLOGY
- Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma
- (2018) Fang Wang et al. HEPATOLOGY
- Immune checkpoint blockade for the treatment of human hepatocellular carcinoma
- (2018) Naoshi Nishida et al. HEPATOLOGY RESEARCH
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis
- (2018) Hualin Zhang et al. ONCOGENE
- Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry
- (2018) Ti-Hao Wang et al. PLoS One
- Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model
- (2018) Shengbin Shi et al. Translational Oncology
- Combination Cancer Immunotherapy in Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
- (2018) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
- (2018) Aldona Kasprzak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
- (2017) Liang Cheng et al. International Journal of Biological Sciences
- Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models
- (2017) Zhen Lu et al. JOURNAL OF HEPATOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Hepatic perivascular mesenchymal stem cells with myogenic properties
- (2017) Sudheer Shenoy P. et al. Journal of Tissue Engineering and Regenerative Medicine
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma
- (2017) Vikrant Rai et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma
- (2017) Wenjing Xiao et al. Experimental and Therapeutic Medicine
- Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2017) Hae Il Jung et al. Cancer Research and Treatment
- Immunoprofiling of Adult-Derived Human Liver Stem/Progenitor Cells: Impact of Hepatogenic Differentiation and Inflammation
- (2017) Hoda El-Kehdy et al. Stem Cells International
- Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective
- (2017) Wuzhen Chen et al. Journal of Immunology Research
- Next-Generation Sequencing and Immunotherapy Biomarkers: A Medical Oncology Perspective
- (2016) Eric Bernicker ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
- (2016) Andrea Kristina Horst et al. Cellular & Molecular Immunology
- Muse Cells, a New Type of Pluripotent Stem Cell Derived from Human Fibroblasts
- (2016) Qi Liu et al. Cellular Reprogramming
- Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
- (2016) Hye-Lim Ju et al. Chinese Journal of Cancer Research
- Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humansin vitro
- (2016) Quan Rao et al. HEPATOLOGY
- Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
- (2016) Alexander M. Lesokhin et al. JOURNAL OF CLINICAL ONCOLOGY
- Gut–liver immunity
- (2016) Palak J. Trivedi et al. JOURNAL OF HEPATOLOGY
- Exosomes derived from dendritic cells improve cardiac function via activation of CD4+ T lymphocytes after myocardial infarction
- (2016) Haibo Liu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors)
- (2016) Jack M Bourke et al. MEDICAL JOURNAL OF AUSTRALIA
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Tetraspanin-8 promotes hepatocellular carcinoma metastasis by increasing ADAM12m expression
- (2016) Tingting Fang et al. Oncotarget
- Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis
- (2016) Oriana Trubiani et al. Stem Cell Research & Therapy
- CD147 handles lipid: a new role for anti-cancer target
- (2016) Daniel J. Felmlee et al. Translational Cancer Research
- Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update
- (2016) Masatoshi Kudo Liver Cancer
- Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
- (2016) Masatoshi Kudo Liver Cancer
- Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
- (2016) Dinh Ha et al. Acta Pharmaceutica Sinica B
- A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
- (2015) Fatima H. Karzai et al. BJU INTERNATIONAL
- Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages
- (2015) Wenjiang Yan et al. GUT
- Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma
- (2015) Guohua Lou et al. Journal of Hematology & Oncology
- CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways
- (2015) Jibin Li et al. JOURNAL OF HEPATOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio
- (2015) Tianzhi Yang et al. PHARMACEUTICAL RESEARCH
- Radioimmunotherapy—a potential novel tool for pancreatic cancer therapy?
- (2015) Marie Sahlin et al. TUMOR BIOLOGY
- Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases’ signaling pathway
- (2015) Jian-Yang Ao et al. TUMOR BIOLOGY
- Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
- (2015) Fang Zheng et al. PLoS Genetics
- A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib
- (2015) AG Duffy et al. United European Gastroenterology Journal
- The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding
- (2015) Shijing Yue et al. Oncotarget
- A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway
- (2014) Yuan Wang et al. CLINICAL & EXPERIMENTAL METASTASIS
- An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer
- (2014) M. S. Gordon et al. CLINICAL CANCER RESEARCH
- CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway
- (2014) Qichao Huang et al. JOURNAL OF HEPATOLOGY
- Randomized Trial of [131I] Metuximab in Treatment of Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation
- (2014) Huijie Bian et al. JNCI-Journal of the National Cancer Institute
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
- (2014) Hidekazu Kawashima TheScientificWorldJOURNAL
- Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma
- (2014) Chong-Ling Duan et al. TUMOR BIOLOGY
- CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF
- (2014) Yan Li et al. TUMOR BIOLOGY
- A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
- (2014) Kentaro Fujiwara et al. EJNMMI Research
- The Role of Natural Killer Cells and CD8+ T Cells in Hepatitis B Virus Infection
- (2014) Anita Schuch et al. Frontiers in Immunology
- The Emerging Role of Exosomes in Epithelial–Mesenchymal-Transition in Cancer
- (2014) Laura Jayne Vella Frontiers in Oncology
- Human CD14+CTLA-4+regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma
- (2013) Yanmei Han et al. HEPATOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- Thyroid hormone suppresses cell proliferation through endoglin-mediated promotion of p21 stability
- (2013) Y-H Lin et al. ONCOGENE
- In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours
- (2012) Raquel Muñoz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
- (2012) B. Sitohy et al. CANCER RESEARCH
- Hepatic Arterial Iodine-131–Labeled Metuximab Injection Combined with Chemoembolization for Unresectable Hepatocellular Carcinoma: Interim Safety and Survival Data from 110 Patients
- (2011) Lu Wu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Overexpression of S100B, TM4SF4, and OLFM4 Genes Is Correlated with Liver Metastasis in Taiwanese Colorectal Cancer Patients
- (2011) Ming-Yii Huang et al. DNA AND CELL BIOLOGY
- HAb18G/CD147 promotes epithelial–mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug
- (2011) J Wu et al. ONCOGENE
- An overview of targeted alpha therapy
- (2011) Young-Seung Kim et al. TUMOR BIOLOGY
- Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma
- (2011) Bao-Ju Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now